ZINACEF

This brand name is authorized in Brazil, Cyprus, Estonia, Finland, Hong Kong, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, United Kingdom, South Africa

Active ingredients

The drug ZINACEF contains one active pharmaceutical ingredient (API):

1 Cefuroxime
UNII R8A7M9MY61 - CEFUROXIME SODIUM

Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death.

Read about Cefuroxime

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZINACEF Powder for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J01DC02 Cefuroxime J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DC Second-generation cephalosporins
Discover more medicines within J01DC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510609001158311
Country: EE Ravimiamet Identifier(s): 1007031, 1007064
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 041013, 058966, 116046
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 39394, 45305, 47403
Country: HK Department of Health Drug Office Identifier(s): 07013, 07014, 07015
Country: IE Health Products Regulatory Authority Identifier(s): 55735, 82384
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3410
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1015682, 1015683, 1017924
Country: MT Medicines Authority Identifier(s): MA685/04301, MA685/04302
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 2782, 2783
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100074314, 100074320
Country: ZA Health Products Regulatory Authority Identifier(s): L/20.1.1/0096, L/20.1.1/0097

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.